Pregnancy rates associated with isotretinoin (Accutane) and the FDA [13]

Journal of the American Academy of Dermatology

Volumn 49, Issue 6, 2003, Pages 1202-1203

  Stashower, Mitchell E ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN;

CLINICAL MEDICINE; DRUG FORMULATION; DRUG USE; FOOD AND DRUG ADMINISTRATION; HUMAN; LETTER; PREGNANCY RATE; PRIORITY JOURNAL;

EID: 0345724845     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(03)02161-3     Document Type: Letter

References (3)

1. Brinker A, Trontell A, Beitz J. Pregnancy and pregnancy rates in association with isotretinoin (Accutane). J Am Acad Dermatol 2002;47:798-9.
2. Strauss JS, Leyden JJ, Lucky AW, Lookingbill DP, Drake LA, et al. Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: a randomized trial comparing micronized isotretinoin with standard isotretinoin. J Am Acad Dermatol 2001;45:196-207.
3. Mitchell AA, Van Bennekom CM, Louik C. A pregnancy prevention program in women of childbearing age receiving isotretinoin. N Engl J Med 1995;333:101-6.